Home › Islet Cell Adenoma › Washington › Seattle
Islet Cell Adenoma clinical trials in Seattle, WA
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Fred Hutchinson Cancer Center, Seattle
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Seattle
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- and 3 more
Islet Cell Adenoma trials in other cities
- Los Angeles, CA5 studies
- Rochester, MN5 studies
- St. Louis, MO5 studies
- Washington, DC4 studies
- Chicago, IL4 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- Salt Lake City, UT4 studies
- Phoenix, AZ4 studies
- Lexington, KY4 studies
- Boston, MA3 studies
- Nashville, TN3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.